Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples

Masimo Corporation2,776 enrolled

Overview

Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.

Noninvasive readings from subjects done according to manufacturer's directions of use compared to simultaneously derived blood samples measured on in vitro analyzers

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Enrollment

2,776

Conditions

Various Comorbidities

Interventions

Noninvasive deviceDEVICE

Noninvasive device

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female of any age ≥ 3 kg. * Subjects may include healthy volunteers, outpatient or inpatient populations Exclusion Criteria: * Subjects with skin abnormalities at the planned application sites that may interfere with sensor application or trans-illumination of the site, such as burns, scar tissue, nail polish, acrylic nails, infections, etc. * Subjects deemed not suitable for study at the discretion of the investigator

Locations (1)

Masimo

Irvine, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.